| 
            Research Area
           | 
   
  
    | 
            Description
           | 
    Cancer | 
   
 
  
    | 
            Biological Activity
           | 
   
  
    | 
            Description
           | 
    PIK-293 is a PI3-K inhibitor for p110α, p110β, p110δ and p110γ with IC50 of 100 μM, 25 μM, 0.24 μM and 10 μM, respectively. | 
   
  
    | 
            Targets
           | 
    p110α | 
    p110β | 
    p110δ | 
    p110γ | 
     | 
     | 
   
  
    | 
            IC50 | 
    100 μM | 
    25 μM | 
    0.24 μM | 
    10 μM [1] | 
     | 
     | 
   
  
    | 
            In Vitro
           | 
    PIK-293 is a pyrazolopyrimidine analog of IC87114. PIK-293 is synthesized by replacing the adenine of IC87114 with the isosteric pyrazolopyrimidine. [1] | 
   
  
    | 
            In Vivo
           | 
     | 
   
  
    | 
            Clinical Trials
           | 
     | 
   
  
    | 
            Features
           | 
     | 
   
 
 |